Wingstop (WING) Fell Along with the Broader Restaurant Industry
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Insider Monkey Blog
Is Twist Bioscience Corporation (TWST) a Compelling Risk-Regarded Opportunity?
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Here’s What Lifted Insmed Incorporated (INSM) in Q3
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Modine Manufacturing Company (MOD) Surged on Increased Demand
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Artisan Small Cap Fund’s Q3 2025 Investor Letter
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” third-quarter 2025 investor letter.
Aristotle Atlantic’s Large Cap Growth Sold Adobe (ADBE) Due to Concerns of Increased Competition
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” third-quarter 2025 investor letter.
Here’s What Makes Shopify (SHOP) an Attractive Investment Choice
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” third-quarter 2025 investor letter.
Aristotle Atlantic’s Large Cap Growth Picked Coinbase Global (COIN) Citing Diverse Growth Signals
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” third-quarter 2025 investor letter.
Visa (V) Fell Due to Slowing Growth Concerns
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” third-quarter 2025 investor letter.
Here’s How an Underweight Exposure to Tesla (TSLA) Impacted Aristotle Atlantic’s Large Cap Growth Strategy
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” third-quarter 2025 investor letter.
Aristotle Atlantic Large Cap Growth Strategy’s Q3 2025 Investor Letter
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” third-quarter 2025 investor letter.
What Makes Capital One Financial Corporation (COF) a Good Investment?
Baron Funds, an investment management company, released its “Baron FinTech Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Morningstar (MORN) Fell Due to a Pullback in the Information Services Sector
Baron Funds, an investment management company, released its “Baron FinTech Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Here’s What Impacted Tradeweb Markets (TW) in Q3
Baron Funds, an investment management company, released its “Baron FinTech Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Fair Isaac Corporation (FICO) Fell Due to Regulatory Pressure
Baron Funds, an investment management company, released its “Baron FinTech Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Should You Hold LPL Financial Holdings (LPLA)?
Baron Funds, an investment management company, released its “Baron FinTech Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Baron FinTech Fund’s Q3 2025 Investor Letter
Baron Funds, an investment management company, released its “Baron FinTech Fund” third-quarter 2025 investor letter.
Here’s Hinde Group’s Investment Thesis for Becton, Dickinson and Company (BDX)
Hinde Group, an investment management company, has released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Hinde Group’s Q3 2025 Investor Letter
Hinde Group, an investment management company, has released its third-quarter 2025 investor letter.
Aristotle Atlantic’s Core Equity Strategy Sold Becton, Dickinson and Company (BDX) Due to Recent Earnings Weakness
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” third-quarter 2025 investor letter. The letter highlighted the market review, ...
What Makes Constellation Energy (CEG) a Lucrative Investment?
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” third-quarter 2025 investor letter. The letter highlighted the market review, ...
Here’s Why Aristotle Atlantic’s Core Equity Strategy Sold Halliburton Company (HAL)
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” third-quarter 2025 investor letter. The letter highlighted the market review, ...
Continued Momentum Lifted Adaptive Biotechnologies Corporation (ADPT) in Q3
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” third-quarter 2025 investor letter. The letter highlighted the market review, ...
Via Transportation, Inc. (NYSE:VIA) Q3 2025 Earnings Call Transcript
Operator: Thank you for standing by. My name is Tina, and I will be your conference operator today.
Innoviz Technologies Ltd. (NASDAQ:INVZW) Q3 2025 Earnings Call Transcript
Innoviz Technologies Ltd. (NASDAQ:INVZW) Q3 2025 Earnings Call Transcript November 12, 2025Innoviz Technologies Ltd. reports earnings inline with expectations.
Gogoro Inc. (NASDAQ:GGROW) Q3 2025 Earnings Call Transcript
Operator: Welcome to the Gogoro Inc. 2025 Third Quarter Earnings Call. This conference call is now being recorded and broadcast live over the Internet.
“It’s Been a Bust,” Says Jim Cramer About StubHub (STUB)
We recently published 10 Stocks Jim Cramer Talked About & Revealed Why He’s Critical Of OpenAI. StubHub Holdings, Inc.
Applied Materials (AMAT) Was Disappointing, Says Jim Cramer
We recently published 10 Stocks Jim Cramer Talked About & Revealed Why He’s Critical Of OpenAI.
“What is This Company?” Wonders Jim Cramer About Bitdeer (BTDR)
We recently published 10 Stocks Jim Cramer Talked About & Revealed Why He’s Critical Of OpenAI.
Jim Cramer’s Must Read Comments About Oracle (ORCL) & OpenAI
Oracle Corporation (NYSE:ORCL) is one of the biggest enterprise resource planning and AI infrastructure providers in the world.
Jim Cramer Discusses NVIDIA (NVDA) Ahead Of Earnings
We recently published 10 Stocks Jim Cramer Talked About & Revealed Why He’s Critical Of OpenAI.
CoreWeave (CRWV) CEO’s Comments Were “Jarring,” Says Jim Cramer
CoreWeave, Inc. (NASDAQ:CRWV)’s shares are up by 93% since their IPO in March but are down 44% over the past month.
Alphabet (GOOGL)’s a Serious Company “That You Want to Buy,” Says Jim Cramer
Jim Cramer has turned increasingly positive on Alphabet Inc. (NASDAQ:GOOGL) as the year nears its end.
I’ll Feel Great About Walmart (WMT)’s New CEO When I Meet Him, Says Jim Cramer
Cramer spent quite some time discussing Walmart Inc. (NYSE:WMT) after the firm’s announcement that its CEO Doug McMillon would retire and be replaced by John Furner.
Costco (COST)’s A Big Position in My Trust, Says Jim Cramer
We recently published 10 Stocks Jim Cramer Talked About & Revealed Why He’s Critical Of OpenAI.
Why These Energy Stocks are Gaining This Week
The energy sector received a major boost from the sharp uptick in natural gas prices, which are now hovering at their highest level since December 2022 on the back of record LNG...
Eightcap Returns with a Market-First for Prop Traders: Customisable Day Trader Challenges
Eightcap is back in the prop space with a new product that allows traders to choose their timeframe, stake, and reward multiplier. This is in addition to the relaunch of Phase...
10 AI Stocks Investors Are Watching
Wall Street has recently been reacting to concerns about inflation and mixed views from bankers about the health of the US economy.
Jim Cramer’s Thoughts on These 17 Stocks
“Every day at 9:30 AM, I'm listening to my partner Carl Quintanilla announce the names of the companies that are coming public on that particular day.
Jim Cramer Laid Out This Week’s Game Plan: 12 Stocks in Focus
Jim Cramer, the host of Mad Money, said Friday that with a new round of earnings reports on the horizon, the market can sometimes get “so darned ugly” that investors have ...
15 Best 52-Week Low Dividend Stocks to Invest In
Dividend stocks have traditionally attracted long-term investors, but they are often overshadowed by flashy growth stocks in terms of popularity.
RBC Capital Remains Bullish on Viridian Therapeutics (VRDN) Following Q3 2025 Results
On November 6, 2025, RBC Capital raised its price target on Viridian Therapeutics, Inc. (NASDAQ:VRDN) from $41 to $45, while maintaining an “Outperform” rating.
UroGen Pharma (URGN) Closes Q3 2025 With $127.4 Million in Cash Amid Rising R&D Costs
On November 6, 2025, UroGen Pharma Ltd. (NASDAQ:URGN) reported its Q3 2025 results, highlighting strong growth in demand alongside its steady commercial expansion.
Raymond James Remains Bullish on Liquidia (LQDA), Cites YUTREPIA’s 75% Growth in U.S. Prostacyclin Revenue
On November 4, 2025, Raymond James raised its price target on Liquidia Corporation (NASDAQ:LQDA) from $41 to $47, while reiterating a “Strong Buy” rating.
Edgewise Therapeutics (EWTX) Reports Heightened R&D Activity in Q3 2025
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) reported its Q3 2025 results on November 6, 2025.
BMO Capital Remains Bullish on Structure Therapeutics (GPCR), Cites Upcoming Trial Readouts
On November 10, 2025, BMO Capital reiterated its “Outperform” rating on Structure Therapeutics Inc. (NASDAQ:GPCR), setting a $100 price target.
H.C. Wainwright Maintains Its Bullish Stance on Vera Therapeutics (VERA), Sees Strong Future Revenue Growth
On November 10, 2025, The Fly reported that H.C. Wainwright increased its price target on Vera Therapeutics, Inc.
Jones Trading Remains Bullish on Janux Therapeutics (JANX) Amid Promising Developments in Prostate Cancer Program
On November 11, 2025, Jones Trading’s Soumit Roy reiterated his “Buy” rating on Janux Therapeutics, Inc.
Jefferies Maintains “Buy” Rating on Wave Life Sciences (WVE) Amid Its Improving Competitive Positioning
On November 13, 2025, Jefferies analyst Roger Song noted that Wave Life Sciences Ltd.
Hedge Fund Resource Center
